📣 VC round data is live. Check it out!

Select Medical Valuation Multiples

Discover Select Medical's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Acadia Healthcare, Huaxia Eye Hospital Group, MLP Sağlık, Dr. Soliman Abdul Kader and more.

Select Medical Overview

About Select Medical

Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.


Founded

2004

HQ

United States

Employees

44.1K

Financials (LTM)

Revenue: $6B
EBITDA: $506M

EV

$5B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Select Medical Financials

Select Medical reported last 12-month revenue of $6B and EBITDA of $506M.

In the same LTM period, Select Medical generated $637M in gross profit, $506M in EBITDA, and $148M in net income.

Revenue (LTM)


Select Medical P&L

In the most recent fiscal year, Select Medical reported revenue of $5B and EBITDA of $531M.

Select Medical is profitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 10%, and net margin of 3%.

See analyst estimates for Select Medical
LTMLast FY202320242025202620272028
Revenue$6B$5B$7B$5B$5B
Gross Profit$637M$629M$932M$634M$629M
Gross Margin11%12%14%12%12%
EBITDA$506M$531M$790M$507M$531M
EBITDA Margin9%10%12%10%10%
EBIT Margin6%6%8%5%6%
Net Profit$148M$146M$243M$214M$146M
Net Margin3%3%4%4%3%
Net Debt-$2B---

Financial data powered by Morningstar, Inc.

Select Medical Stock Performance

Select Medical has current market cap of $2B, and enterprise value of $5B.

Market Cap Evolution


Select Medical's stock price is $16.51.

Select Medical share price increased by 0.1% in the last 30 days, and by 8.8% in the last year.

Select Medical has an EPS (earnings per share) of $1.18.

See more trading valuation data for Select Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5B$2B0.1%0.1%1.4%8.8%$1.18

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Select Medical Valuation Multiples

Select Medical trades at 0.9x EV/Revenue multiple, and 9.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Select Medical

EV / Revenue (LTM)


Select Medical Financial Valuation Multiples

As of June 2, 2026, Select Medical has market cap of $2B and EV of $5B.

Select Medical has a P/E ratio of 13.8x.

LTMLast FY202320242025202620272028
EV/Revenue0.9x0.9x0.8x1.0x0.9x
EV/EBITDA9.9x9.4x6.3x9.9x9.4x
EV/EBIT14.4x14.9x9.0x18.7x14.9x
EV/Gross Profit7.9x8.0x5.4x7.9x8.0x
P/E13.8x14.0x8.4x9.6x14.0x
EV/FCF-42.8x14.2x17.0x42.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Select Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Select Medical Margins & Growth Rates

Select Medical grew revenue by 4% but EBITDA decreased by 1% in the last fiscal year.

In the most recent fiscal year, Select Medical reported gross margin of 12%, EBITDA margin of 10%, and net margin of 3%.

See estimated margins and future growth rates for Select Medical

Select Medical Margins

Last FY202420252026202720282029
Gross Margin12%12%12%11%
EBITDA Margin10%10%10%9%
EBIT Margin6%5%6%6%
Net Margin3%4%3%3%
FCF Margin2%6%2%-

Select Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%(22%)5%4%
Gross Profit Growth3%(32%)(1%)3%
EBITDA Growth(1%)(36%)5%(1%)
EBIT Growth9%(52%)25%9%
Net Profit Growth3%(12%)(32%)3%
FCF Growth-(16%)(60%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Select Medical Operational KPIs

Select Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Select Medical's Rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Select Medical's Rule of X is 20% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Select Medical
LTMLast FY202320242025202620272028
Rule of 4014%14%---
Bessemer Rule of X20%20%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue3%3%3%4%3%
Opex to Revenue-5%6%7%5%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Select Medical Competitors

Select Medical competitors include Acadia Healthcare, Huaxia Eye Hospital Group, MLP Sağlık, Dr. Soliman Abdul Kader, Astrana Health, Akdital, Draegerwerk, Pediatrix, Surgery Partners and Siloam Hospitals.

Most Select Medical public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Acadia Healthcare1.4x1.4x7.6x7.7x
Huaxia Eye Hospital Group2.9x2.8x12.5x13.1x
MLP Sağlık1.7x1.5x5.3x5.5x
Dr. Soliman Abdul Kader3.3x2.8x16.6x17.0x
Astrana Health0.8x0.7x12.0x10.6x
Akdital4.4x3.7x14.8x13.3x
Draegerwerk0.4x0.4x3.9x3.9x
Pediatrix1.1x1.1x7.5x7.4x

This data is available for Pro users. Sign up to see all Select Medical competitors and their valuation data.

Start Free Trial

Acquisitions by Select Medical

Select Medical has acquired 5 companies to date.

Last acquisition by Select Medical was on December 9th 2025. Select Medical acquired Landmark Hospital of Savannah for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Select Medical

Landmark Hospital of Savannah
Baptist Memorial Restorative Care Hospital
Valir Rehabilitation Hospital
Physiotherapy Associates
Description
Landmark Hospital of Savannah is a long-term acute care hospital in Georgia delivering specialized treatment for critically ill patients requiring extended medical recovery.
Baptist Memorial Restorative Care Hospital is a long-term acute care facility in Memphis, Tennessee. Affiliated with Baptist Memorial Health Care, the 52-bed hospital treats patients recovering from critical illnesses, surgeries, or ventilator dependence, providing intensive medical rehabilitation, wound care, and pulmonary services. It addresses complex conditions like sepsis, trauma, and multi-organ failure in a specialized environment bridging ICU and traditional rehab settings.
Valir Rehabilitation Hospital is an acute care facility in Oklahoma City providing inpatient rehabilitation for neurological, orthopedic, and cardiac conditions. The 55-bed hospital offers physical, occupational, and speech therapies with specialized units for stroke recovery and brain injury. Part of the Valir Health system, it admits patients from 40 hospitals regionally, achieving CARF accreditation for comprehensive programs including amputee care and spinal cord injury rehabilitation.
Physiotherapy Associates is a United Kingdom-headquartered national provider of outpatient physical rehabilitation services. Operating over 200 clinics, it delivers orthopedic, spinal, neurological rehab, orthotics, and prosthetics care through therapist-led programs. Partnered with private medical insurers and the NHS, the network treats workplace injuries, post-op recovery, and chronic pain conditions across England and Wales.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
-
Memphis, TN
Oklahoma City, OK
Philadelphia, PA
Deal Date9 Dec 202517 Apr 20254 Sep 202425 Jan 2016
Valuationundisclosedundisclosedundisclosed$400M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Select Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Select Medical

When was Select Medical founded?Select Medical was founded in 2004.
Where is Select Medical headquartered?Select Medical is headquartered in United States.
How many employees does Select Medical have?As of today, Select Medical has over 44K employees.
Who is the CEO of Select Medical?Select Medical's CEO is Thomas P. Mullin.
Is Select Medical publicly listed?Yes, Select Medical is a public company listed on NYSE.
What is the stock symbol of Select Medical?Select Medical trades under SEM ticker.
When did Select Medical go public?Select Medical went public in 2009.
Who are competitors of Select Medical?Select Medical main competitors include Acadia Healthcare, Huaxia Eye Hospital Group, MLP Sağlık, Dr. Soliman Abdul Kader, Astrana Health, Akdital, Draegerwerk, Pediatrix, Surgery Partners, Siloam Hospitals.
What is the current market cap of Select Medical?Select Medical's current market cap is $2B.
What is the current revenue of Select Medical?Select Medical's last 12 months revenue is $6B.
What is the current revenue growth of Select Medical?Select Medical revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Select Medical?Current revenue multiple of Select Medical is 0.9x.
What is the current EBITDA of Select Medical?Select Medical's last 12 months EBITDA is $506M.
What is Select Medical's EBITDA margin?Select Medical's last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Select Medical?Current EBITDA multiple of Select Medical is 9.9x.
How many companies Select Medical has acquired to date?As of June 2026, Select Medical has acquired 5 companies.
What was the largest acquisition by Select Medical?$1B acquisition of Concentra Group on 23rd March 2015 was the largest M&A Select Medical has done to date.
What companies Select Medical acquired?Select Medical acquired Concentra Group, Physiotherapy Associates, Landmark Hospital of Savannah, Baptist Memorial Restorative Care Hospital, and Valir Rehabilitation Hospital.
In how many companies Select Medical has invested to date?Select Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Select Medical

Lists including Select Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial